|
|
| New Whitepaper: Insights into MSC-Based Therapies | Discover key advancements in MSC-based therapies with insights from Corning's Field Application Scientists. Explore methods for MSC isolation, production considerations, media options, cell expansion technologies, and cGMP manufacturing. Gain valuable learnings from collaborations with academic researchers, biotech, and pharmaceutical companies, featuring real-world case studies. Whether you're scaling for clinical applications or advancing research, this whitepaper provides actionable strategies to optimize MSC production and push the boundaries of therapeutic development. |
|
|
|
|
A conversation with Devyn Smith, Ph.D., and Pam Stetkiewicz, Ph.D. — Arbor Biotechnologies | Following recent news about first-in-human testing, two executives discuss the science and manufacturing strategy for the company's lead candidate, ABO-101. | |
|
|
|
| EVs Answer To The CAR-Tease: Targeted Exosomes | Article | RoosterBio | Researchers are exploring extracellular vesicles to deliver CARs, potentially offering safer, more accessible, and effective treatments compared to current CAR-T cell therapies. |
|
|
| CD8+ Single Positive T Cell Differentiation From HiPSC | Poster | By Lianbin Chen, Xing Zhang, Zhaolu Yan, Na Zhang, et al., ACROBiosystems | Learn about a feeder-free method to differentiate CD8+ single positive T cells from human induced pluripotent stem cells, which offers promising advancements for scalable and efficient cell therapies. |
|
|
|
|
| Flow Cytometric Assays For CAR-T Cell Manufacturing | Webinar | Miltenyi Biotec | Join Dr. Stephen Wilmes, PhD, as he explores the critical role of flow cytometry in analyzing CAR-T cell products to focus on identity, purity, potency, and new technologies enhancing assay sensitivity. |
|
|
|
| Ways To Enhance Access To Cell Therapies | e-book | Terumo BCT | Cell therapies are revolutionizing cancer care, but their complex manufacturing and high costs bar access for many patients. Automation is emerging as an efficacious solution to reach patients in need. |
|
|
|
| Mixing Modes In IRO For CAR-T Manufacturing | Application Note | Ori Biotech | Unlock superior cell and gene therapy manufacturing with IRO's novel bioreactor geometry and flexible operating parameters for optimal control. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
Connect With Cell & Gene: |
|
|
|